
Oncologist

No OPD information available
Breast Cancer
Bone Tumor
HER-2 Positive Breast Cancer
Kienbock's Disease
Lung Cancer
Mastectomy
Menopause
Metastatic Brain Tumor
Mycobacterium Avium Complex Infections
Non-Small Cell Lung Cancer (NSCLC)
Osteonecrosis
Small Cell Lung Cancer (SCLC)
Triple-Negative Breast Cancer
Richard H. De Boer is a male medical professional who helps patients with different health conditions like breast cancer, bone tumor, lung cancer, and more. He specializes in treating various types of cancers and other complex health issues.
Richard H. De Boer uses his special skills and knowledge to provide the best care for his patients. He is known for his expertise in treating conditions like HER-2 positive breast cancer, Kienbock's disease, and metastatic brain tumor. Patients trust him because he communicates clearly and compassionately, making sure they understand their treatment options and feel supported throughout their healthcare journey.
To stay updated with the latest medical knowledge and research, Richard H. De Boer regularly attends conferences, reads medical journals, and collaborates with other healthcare professionals. This helps him provide the most effective and up-to-date treatments for his patients.
Richard H. De Boer works closely with his colleagues and other medical professionals to ensure that patients receive comprehensive and coordinated care. By sharing knowledge and expertise, they create a supportive environment that benefits patients and improves their overall health outcomes.
Through his work, Richard H. De Boer has positively impacted many patients' lives. His research on pembrolizumab in triple negative breast cancer has contributed to advancements in cancer treatment. Additionally, his involvement in clinical trials, such as the one evaluating the efficacy and safety of palbociclib in metastatic breast cancer, shows his commitment to improving patient care and outcomes.
In summary, Richard H. De Boer is a dedicated and skilled medical professional who provides high-quality care to patients facing challenging health conditions. His commitment to staying updated with the latest research and collaborating with colleagues demonstrates his passion for improving patient outcomes and making a positive impact in the medical field.
Enrollment Status: Active not recruiting
Published: January 13, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
